|
|
|
|
|
|
| Mobile Research Units Enable Large-Volume Screenings | Case Study | PCM Trials | Learn how recruitment and screening of potential patients was made possible for a Phase 3, adult patient, clinical trial by utilizing MRUs to screen large volumes of patients at community events. |
|
|
|
| Trial Site Selection And Design Insights For Neurodegenerative Diseases | Guest Column | A conversation with Lahar Mehta, MD, Amylyx Pharmaceuticals | Amylyx’s head of global clinical development, Lahar Mehta, MD, talks multi-stakeholder trial design, purposeful site selection, caregiver burden, and the benefits of an open label extension (OLE), among other contributing factors. |
|
|
| The Annual Clinical Trials Roundup | White Paper | By Heidi Chen, Citeline | Delve into in-depth analyses of key diseases, players, and geographies influencing the pharmaceutical industry through an overview of Phase 1-3 clinical trials initiated in 2022 across all therapeutic areas. |
|
|
|
|
|
| Clinical Trial Start-Up: Insights From The Industry | Article | By Meghan Hosely, Advarra | Uncover key survey findings gleaned from the perspectives of over 500 clinical researchers regarding technological trends and recommendations for enhancing the overall site experience. |
|
|
|
|
| A Smart Solution To Clinical Supply Management | Application Note | By Carolyn Timpany, Lisa Spence, and Ed Groleau, PCI Pharma Services | Delve into a solution that ensures the efficient delivery of trial materials worldwide, while navigating the challenges of more complex study designs and the ever-evolving regulatory landscape. |
|
|
|
| Let’s Take On Rare Disease Research Together | Brochure | Premier Research | Learn how significant experience with natural history studies, precision medicine, and real-world data planning, trial design, and regulatory strategy can guide rare disease product development. |
|
|
| Clinical Trial Label Services | Brochure | Thermo Fisher Scientific | Examine how printing labels with speed, efficiency, reliability, and accuracy can help ensure clinical trial timeline accuracy and improve the potential for successful NDAs. |
|
|
|
| Global Pharmacovigilance And Risk Management Strategies Conference | Baltimore Marriott Waterfront | February 5, 2024, 7:00 a.m. — February 7, 2024, 6:00 p.m. DIA's Global Pharmacovigilance and Risk Management Strategies Conference is a neutral event developed by regulators and industry experts discussing the updates, opportunities, and challenges alongside fresh problem-solving strategies that matter most to safety professionals. Secure your early bird rate today! |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Tuesday edition of the Clinical Leader newsletter, focusing on Clinical Trial Technology. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
Connect With Clinical Leader: |
|
|
|